Tsai et al. reported that 5-aza-CdR, a DNA methyltransferase inhibitor, had an anticancer effect on AID+ hematopoietic cancer cells by downregulating AID [33]. The gene discussed is AICDA; the disease is hematopoietic and lymphoid cell neoplasm.